Innate immunity receptors in depression and suicide: upregulated NOD-like receptors containing pyrin (NLRPs) and hyperactive inflammasomes in the postmortem brains of people who were depressed and died by suicide

Abnormalities of inflammation have been implicated in the pathophysiology of depression and suicide, based on observations of increased levels of proinflammatory cytokines in the serum of people who were depressed and died by suicide. More recently, abnormalities in cytokines and innate immunity rec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of psychiatry & neuroscience Jg. 46; H. 5; S. E538 - E547
Hauptverfasser: Pandey, Ghanshyam N., Zhang, Hui, Sharma, Anuradha, Ren, Xinguo
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Canada Canadian Medical Association 01.09.2021
NRC Research Press
CMA Joule Inc
Schlagworte:
ISSN:1180-4882, 1488-2434, 1488-2434
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Abnormalities of inflammation have been implicated in the pathophysiology of depression and suicide, based on observations of increased levels of proinflammatory cytokines in the serum of people who were depressed and died by suicide. More recently, abnormalities in cytokines and innate immunity receptors such as toll-like receptors have also been observed in the postmortem brains of people who were depressed and died by suicide. In addition to toll-like receptors, another subfamily of innate immunity receptors known as NOD-like receptors containing pyrin (NLRPs) are the most widely present NOD-like receptors in the central nervous system. NLRPs also form inflammasomes that play an important role in brain function. We studied the role of NLRPs in depression and suicide. We determined the protein and mRNA expression of NLRP1, NLRP3 and NLRP6 and the components of their inflammasomes (i.e., adaptor molecule apoptosis-associated speck-like protein [ASC], caspase1, caspase3, interleukin [IL]-1β and IL-18) postmortem in the prefrontal cortex of people who were depressed and died by suicide, and in healthy controls. We determined mRNA levels using quantitative polymerase chain reaction, and we determined protein expression using Western blot immunolabelling. We found that the protein and mRNA expression levels of NLRP1, NLRP3, NLRP6, caspase3 and ASC were significantly increased in people who were depressed and died by suicide compared to healthy controls. Some people who were depressed and died by suicide were taking antidepressant medication at the time of their death. Similar to toll-like receptors, NLRP and its inflammasomes were upregulated in people who were depressed and died by suicide compared to healthy controls. Innate immunity receptors in general — and NLRPs and inflammasomes in particular — may play an important role in the pathophysiology of depression and suicide.
AbstractList ABSTRACTBackgroundAbnormalities of inflammation have been implicated in the pathophysiology of depression and suicide, based on observations of increased levels of proinflammatory cytokines in the serum of people who were depressed and died by suicide. More recently, abnormalities in cytokines and innate immunity receptors such as toll-like receptors have also been observed in the postmortem brains of people who were depressed and died by suicide. In addition to toll-like receptors, another subfamily of innate immunity receptors known as NOD-like receptors containing pyrin (NLRPs) are the most widely present NOD-like receptors in the central nervous system. NLRPs also form inflammasomes that play an important role in brain function. We studied the role of NLRPs in depression and suicide. MethodsWe determined the protein and mRNA expression of NLRP1, NLRP3 and NLRP6 and the components of their inflammasomes (i.e., adaptor molecule apoptosis-associated speck-like protein [ASC], caspase1, caspase3, interleukin [IL]-1β and IL-18) postmortem in the prefrontal cortex of people who were depressed and died by suicide, and in healthy controls. We determined mRNA levels using quantitative polymerase chain reaction, and we determined protein expression using Western blot immunolabelling. ResultsWe found that the protein and mRNA expression levels of NLRP1, NLRP3, NLRP6, caspase3 and ASC were significantly increased in people who were depressed and died by suicide compared to healthy controls. LimitationsSome people who were depressed and died by suicide were taking antidepressant medication at the time of their death. ConclusionSimilar to toll-like receptors, NLRP and its inflammasomes were upregulated in people who were depressed and died by suicide compared to healthy controls. Innate immunity receptors in general — and NLRPs and inflammasomes in particular — may play an important role in the pathophysiology of depression and suicide.
Abnormalities of inflammation have been implicated in the pathophysiology of depression and suicide, based on observations of increased levels of proinflammatory cytokines in the serum of people who were depressed and died by suicide. More recently, abnormalities in cytokines and innate immunity receptors such as toll-like receptors have also been observed in the postmortem brains of people who were depressed and died by suicide. In addition to toll-like receptors, another subfamily of innate immunity receptors known as NOD-like receptors containing pyrin (NLRPs) are the most widely present NOD-like receptors in the central nervous system. NLRPs also form inflammasomes that play an important role in brain function. We studied the role of NLRPs in depression and suicide. We determined the protein and mRNA expression of NLRP1, NLRP3 and NLRP6 and the components of their inflammasomes (i.e., adaptor molecule apoptosis-associated speck-like protein [ASC], caspase1, caspase3, interleukin [IL]-1β and IL-18) postmortem in the prefrontal cortex of people who were depressed and died by suicide, and in healthy controls. We determined mRNA levels using quantitative polymerase chain reaction, and we determined protein expression using Western blot immunolabelling. We found that the protein and mRNA expression levels of NLRP1, NLRP3, NLRP6, caspase3 and ASC were significantly increased in people who were depressed and died by suicide compared to healthy controls. Some people who were depressed and died by suicide were taking antidepressant medication at the time of their death. Similar to toll-like receptors, NLRP and its inflammasomes were upregulated in people who were depressed and died by suicide compared to healthy controls. Innate immunity receptors in general - and NLRPs and inflammasomes in particular - may play an important role in the pathophysiology of depression and suicide.
Abnormalities of inflammation have been implicated in the pathophysiology of depression and suicide, based on observations of increased levels of proinflammatory cytokines in the serum of people who were depressed and died by suicide. More recently, abnormalities in cytokines and innate immunity receptors such as toll-like receptors have also been observed in the postmortem brains of people who were depressed and died by suicide. In addition to toll-like receptors, another subfamily of innate immunity receptors known as NOD-like receptors containing pyrin (NLRPs) are the most widely present NOD-like receptors in the central nervous system. NLRPs also form inflammasomes that play an important role in brain function. We studied the role of NLRPs in depression and suicide.BACKGROUNDAbnormalities of inflammation have been implicated in the pathophysiology of depression and suicide, based on observations of increased levels of proinflammatory cytokines in the serum of people who were depressed and died by suicide. More recently, abnormalities in cytokines and innate immunity receptors such as toll-like receptors have also been observed in the postmortem brains of people who were depressed and died by suicide. In addition to toll-like receptors, another subfamily of innate immunity receptors known as NOD-like receptors containing pyrin (NLRPs) are the most widely present NOD-like receptors in the central nervous system. NLRPs also form inflammasomes that play an important role in brain function. We studied the role of NLRPs in depression and suicide.We determined the protein and mRNA expression of NLRP1, NLRP3 and NLRP6 and the components of their inflammasomes (i.e., adaptor molecule apoptosis-associated speck-like protein [ASC], caspase1, caspase3, interleukin [IL]-1β and IL-18) postmortem in the prefrontal cortex of people who were depressed and died by suicide, and in healthy controls. We determined mRNA levels using quantitative polymerase chain reaction, and we determined protein expression using Western blot immunolabelling.METHODSWe determined the protein and mRNA expression of NLRP1, NLRP3 and NLRP6 and the components of their inflammasomes (i.e., adaptor molecule apoptosis-associated speck-like protein [ASC], caspase1, caspase3, interleukin [IL]-1β and IL-18) postmortem in the prefrontal cortex of people who were depressed and died by suicide, and in healthy controls. We determined mRNA levels using quantitative polymerase chain reaction, and we determined protein expression using Western blot immunolabelling.We found that the protein and mRNA expression levels of NLRP1, NLRP3, NLRP6, caspase3 and ASC were significantly increased in people who were depressed and died by suicide compared to healthy controls.RESULTSWe found that the protein and mRNA expression levels of NLRP1, NLRP3, NLRP6, caspase3 and ASC were significantly increased in people who were depressed and died by suicide compared to healthy controls.Some people who were depressed and died by suicide were taking antidepressant medication at the time of their death.LIMITATIONSSome people who were depressed and died by suicide were taking antidepressant medication at the time of their death.Similar to toll-like receptors, NLRP and its inflammasomes were upregulated in people who were depressed and died by suicide compared to healthy controls. Innate immunity receptors in general - and NLRPs and inflammasomes in particular - may play an important role in the pathophysiology of depression and suicide.CONCLUSIONSimilar to toll-like receptors, NLRP and its inflammasomes were upregulated in people who were depressed and died by suicide compared to healthy controls. Innate immunity receptors in general - and NLRPs and inflammasomes in particular - may play an important role in the pathophysiology of depression and suicide.
Background: Abnormalities of inflammation have been implicated in the pathophysiology of depression and suicide, based on observations of increased levels of proinflammatory cytokines in the serum of people who were depressed and died by suicide. More recently, abnormalities in cytokines and innate immunity receptors such as toll-like receptors have also been observed in the postmortem brains of people who were depressed and died by suicide. In addition to toll-like receptors, another subfamily of innate immunity receptors known as NOD-like receptors containing pyrin (NLRPs) are the most widely present NOD-like receptors in the central nervous system. NLRPs also form inflammasomes that play an important role in brain function. We studied the role of NLRPs in depression and suicide. Methods: We determined the protein and mRNA expression of NLRP1, NLRP3 and NLRP6 and the components of their inflammasomes (i.e., adaptor molecule apoptosis-associated speck-like protein [ASC], caspase1, caspase3, interleukin [IL]-1 p and IL-18) postmortem in the prefrontal cortex of people who were depressed and died by suicide, and in healthy controls. We determined mRNA levels using quantitative polymerase chain reaction, and we determined protein expression using Western blot immunolabelling. Results: We found that the protein and mRNA expression levels of NLRP1, NLRP3, NLRP6, caspase3 and ASC were significantly increased in people who were depressed and died by suicide compared to healthy controls. Limitations: Some people who were depressed and died by suicide were taking antidepressant medication at the time of their death. Conclusion: Similar to toll-like receptors, NLRP and its inflammasomes were upregulated in people who were depressed and died by suicide compared to healthy controls. Innate immunity receptors in general--and NLRPs and inflammasomes in particular--may play an important role in the pathophysiology of depression and suicide.
Audience Academic
Author Ren, Xinguo
Zhang, Hui
Sharma, Anuradha
Pandey, Ghanshyam N.
Author_xml – sequence: 1
  givenname: Ghanshyam N.
  surname: Pandey
  fullname: Pandey, Ghanshyam N.
  email: gnpandey@uic.edu
– sequence: 2
  givenname: Hui
  surname: Zhang
  fullname: Zhang, Hui
– sequence: 3
  givenname: Anuradha
  surname: Sharma
  fullname: Sharma, Anuradha
– sequence: 4
  givenname: Xinguo
  surname: Ren
  fullname: Ren, Xinguo
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34588173$$D View this record in MEDLINE/PubMed
BookMark eNp1k9tq3DAQhk1JaQ7tTR-giPYmLTiV5MPKuSiE9BQISenhWmjl8a4SWXIkecO-Zx-os9lsScoWgy3J_3wzjP7Zz3acd5BlLxk9YhUt3l8N7ogzSln9JNtjpRA5L4tyB9dM0Bz3fDfbj_GKUsopq55lu0VZCcEmxV72-8w5lYCYvh-dSUsSQMOQfIjEONLCECBG4x1RriVxNNq0cExGPJ6NFgNbcnH5MbfmGh5Eau-SMs64GRmWATmHF-ffv8W3d5D5coCgdDILzOo6q_peRd_DXcI0BzL4mHofEvRkGhATie_IAH6wQG7nntxCgE1lmH_FbA0upstNgc-zp52yEV7cfw-yX58__Tz9mp9ffjk7PTnPdU1FyjnXmgmhsBvlhCmmS90UtSqaqpw2k6JrhYayU12Bby4Ym5aNogXqmloXdALFQfZhzR3GaQ-tBpeCsnIIpldhKb0y8vEfZ-Zy5hdSVLxmXCDg8B4Q_M0IMcneRA3WKgd-jJJXE8Eq3jQUpW_W0pmyILFxHol6JZcnNRYnyrJaqfItqhk4bLlF13QGjx_pX2_R68HcyIeioy0ifFrojd5KffWwL38bsrEdCuhaoIOPMUAntUkqoc-QbKxkVK6cLdHZcu1sDHn3T8iGulV8fzGAt78wEKS26Eet7DUsIV75MTg0hmQycknlj9WgrOaEFzgjNS0RwP8PkK0327L-Ae5JIic
CitedBy_id crossref_primary_10_2147_PRBM_S463316
crossref_primary_10_1016_j_pnpbp_2025_111325
crossref_primary_10_1016_j_bbih_2024_100853
crossref_primary_10_1186_s12906_025_04939_2
crossref_primary_10_3389_fphar_2024_1381523
crossref_primary_10_1080_14728222_2023_2225216
crossref_primary_10_1016_j_brainresbull_2025_111405
crossref_primary_10_1016_j_intimp_2023_111030
crossref_primary_10_1007_s11033_024_09293_z
crossref_primary_10_1007_s11064_024_04323_5
crossref_primary_10_3389_fcell_2022_842320
crossref_primary_10_1016_j_phymed_2025_156394
crossref_primary_10_1016_j_brainres_2023_148644
crossref_primary_10_1038_s41380_025_02951_z
crossref_primary_10_3389_fimmu_2025_1642001
crossref_primary_10_1016_j_bbr_2024_115413
crossref_primary_10_1038_s41423_025_01275_w
crossref_primary_10_1007_s12035_024_04284_4
crossref_primary_10_3390_brainsci12081057
crossref_primary_10_1016_j_expneurol_2024_114937
crossref_primary_10_1016_j_exger_2024_112451
crossref_primary_10_1176_appi_focus_20220078
crossref_primary_10_1016_j_brainresbull_2024_111056
crossref_primary_10_1016_j_jad_2023_06_050
crossref_primary_10_1016_j_cytogfr_2024_10_004
crossref_primary_10_3389_fncel_2022_863426
crossref_primary_10_1007_s12035_022_03199_2
crossref_primary_10_1016_j_jad_2024_08_144
crossref_primary_10_3389_fimmu_2024_1479471
crossref_primary_10_1016_j_neurot_2023_10_010
crossref_primary_10_1016_j_bbi_2025_04_015
crossref_primary_10_3390_ijms25189776
crossref_primary_10_3390_ijms24010133
crossref_primary_10_3390_ph18060867
crossref_primary_10_1016_j_neuroscience_2023_11_029
crossref_primary_10_1503_jpn_220206
crossref_primary_10_2147_JIR_S501652
crossref_primary_10_1016_j_phrs_2022_106625
crossref_primary_10_1089_ars_2022_0180
Cites_doi 10.1016/j.coph.2011.07.002
10.1016/j.bbi.2012.12.008
10.1016/j.cell.2010.01.040
10.3109/08830185.2010.529976
10.1111/j.1471-4159.2011.07481.x
10.1016/j.biopsych.2009.09.033
10.1164/rccm.200808-1274OC
10.1503/jpn.170192
10.1016/j.psyneuen.2008.10.006
10.1016/j.bbi.2013.10.017
10.1016/S1359-6101(98)00004-5
10.1038/ni.1980
10.1016/j.biopsych.2014.10.014
10.1016/j.coi.2008.01.003
10.1016/j.gene.2004.05.002
10.1016/j.jpsychires.2015.10.015
10.4049/jimmunol.0901363
10.1111/bpa.12478
10.1126/science.1184003
10.1038/s41577-019-0165-0
10.1038/nature02664
10.1016/j.pnpbp.2004.11.003
10.1016/j.bbi.2018.09.024
10.1038/nature09663
10.1371/journal.ppat.0030111
10.1038/nature11729
10.1016/j.neurobiolaging.2007.06.006
10.1038/ni.1703
10.1038/jcbfm.2013.227
10.1038/nature04516
10.1016/j.jpsychires.2014.01.021
10.1016/S1097-2765(02)00599-3
10.1016/S0021-9258(19)52451-6
10.1007/s12026-012-8272-z
10.1016/j.neubiorev.2008.10.005
10.1016/j.cell.2010.02.016
10.1007/s12035-015-9408-7
10.1001/archgenpsychiatry.2010.22
10.1038/ni.3333
10.1111/j.1600-0447.2007.01128.x
10.1016/j.neuron.2013.04.005
10.1016/j.neuron.2018.08.001
10.1016/j.tcb.2014.12.009
10.1038/nrmicro2070
10.1016/j.jpsychires.2011.08.006
10.1016/j.immuni.2009.04.012
10.1016/j.cell.2010.01.022
10.1016/j.immuni.2013.08.001
10.1016/S0893-133X(01)00327-X
10.4049/jimmunol.0713552
10.1038/nrn.2016.69
10.1038/ni.2237
10.1016/j.bbi.2014.04.007
10.1016/j.euroneuro.2013.06.002
10.1016/S1074-7613(04)00046-9
ContentType Journal Article
Copyright 2021 CMA Joule Inc. or its licensors
CMA Joule Inc. or its licensors
2021 CMA Joule Inc. or its licensors.
COPYRIGHT 2021 NRC Research Press
2021 CMA Joule Inc. or its licensors 2021
Copyright_xml – notice: 2021 CMA Joule Inc. or its licensors
– notice: CMA Joule Inc. or its licensors
– notice: 2021 CMA Joule Inc. or its licensors.
– notice: COPYRIGHT 2021 NRC Research Press
– notice: 2021 CMA Joule Inc. or its licensors 2021
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1503/jpn.210016
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1488-2434
EndPage E547
ExternalDocumentID PMC8526128
A681184450
34588173
10_1503_jpn_210016
1_s2_0_S1180488223000604
S1180488223000604
Genre Journal Article
GeographicLocations United States
GeographicLocations_xml – name: United States
GroupedDBID ---
.1-
.FO
1P~
29L
2WC
36B
4.4
5GY
5RS
6PF
7RV
7X7
88E
88I
8AF
8AO
8FI
8FJ
8FQ
8G5
AAFWJ
AAWTL
ABIVO
ABUWG
ACGFO
ACGOD
ACHQT
ACPRK
ADBBV
AENEX
AEVXI
AFKRA
AFRHN
AHMBA
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AN0
AZQEC
BAWUL
BENPR
BKEYQ
BLC
BNQBC
BPHCQ
BVXVI
CCPQU
DIK
DU5
DWQXO
E3Z
EBD
EBS
EMB
EMOBN
EX3
F5P
FEDTE
FYUFA
GNUQQ
GUQSH
GX1
HCIFZ
HMCUK
HVGLF
HYE
IAO
ICQ
IEA
IHR
IHW
INH
INR
IOF
IPO
IPY
ISN
ISR
ITC
M1P
M2M
M2O
M2P
M2Q
M3G
M5~
NAPCQ
OH0
OK1
OU-
OVD
OVT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PSYQQ
PV9
Q2X
RDH
RNS
RPM
RWL
RXW
RZL
SV3
TAE
TR2
UKHRP
W2D
WOW
XSB
Z5R
3V.
53G
AAKAS
ADZCM
AFCTW
ALIPV
BCGST
BCR
EJD
M~E
RHF
TEORI
WOQ
ZXP
AAYXX
AFFHD
BAIFH
BBTPI
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c608t-22cc188a345471a1c4c936a3954b973fd8ce4faf3e4f2811b49a03a1c96c307e3
ISICitedReferencesCount 44
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000708626700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1180-4882
1488-2434
IngestDate Tue Nov 04 01:42:13 EST 2025
Fri Sep 05 09:52:53 EDT 2025
Tue Nov 11 10:45:56 EST 2025
Mon Nov 24 15:49:38 EST 2025
Wed Aug 20 01:30:39 EDT 2025
Tue Nov 04 18:10:50 EST 2025
Thu Apr 03 07:05:08 EDT 2025
Sat Nov 29 07:38:54 EST 2025
Tue Nov 18 20:40:04 EST 2025
Sun Feb 23 10:19:00 EST 2025
Tue Oct 14 19:34:21 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License http://www.nrcresearchpress.com/page/about/CorporateTextAndDataMining
2021 CMA Joule Inc. or its licensors.
This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c608t-22cc188a345471a1c4c936a3954b973fd8ce4faf3e4f2811b49a03a1c96c307e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC8526128
PMID 34588173
PQID 2578152990
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8526128
proquest_miscellaneous_2578152990
gale_infotracmisc_A681184450
gale_infotracgeneralonefile_A681184450
gale_infotraccpiq_681184450
gale_infotracacademiconefile_A681184450
pubmed_primary_34588173
crossref_citationtrail_10_1503_jpn_210016
crossref_primary_10_1503_jpn_210016
elsevier_clinicalkeyesjournals_1_s2_0_S1180488223000604
elsevier_clinicalkey_doi_10_1503_jpn_210016
PublicationCentury 2000
PublicationDate 2021-Sep
PublicationDateYYYYMMDD 2021-09-01
PublicationDate_xml – month: 09
  year: 2021
  text: 2021-Sep
PublicationDecade 2020
PublicationPlace Canada
PublicationPlace_xml – name: Canada
PublicationTitle Journal of psychiatry & neuroscience
PublicationTitleAlternate J Psychiatry Neurosci
PublicationYear 2021
Publisher Canadian Medical Association
NRC Research Press
CMA Joule Inc
Publisher_xml – name: Canadian Medical Association
– name: NRC Research Press
– name: CMA Joule Inc
References Lampron, Elali, Rivest (bb0060) 2013; 78
Alcocer-Gomez, Ulecia-Moron, Marin-Aguilar (bb0190) 2016; 53
Ye, Ting (bb0070) 2008; 20
Mariathasan, Newton, Monack (bb0225) 2004; 430
Iyer, He, Janczy (bb0230) 2013; 39
Heneka, Kummer, Stutz (bb0285) 2013; 493
Schroder, Zhou, Tschopp (bb0155) 2010; 327
Xu, Murphy, Kochanek (bb0010) 2020
Rathinam, Vanaja, Fitzgerald (bb0080) 2012; 13
Serafini, Pompili, Elena Seretti (bb0035) 2013; 23
Kim, Andreazza, Elmi (bb0175) 2016; 72
White, Lawrence, Brough (bb0305) 2017; 27
Zhou, Yazdi, Menu (bb0235) 2011; 469
Griffith, Sun, McIntosh (bb0250) 2009; 183
Bauernfeind, Horvath, Stutz (bb0210) 2009; 183
Franchi, Eigenbrod, Munoz-Planillo (bb0065) 2009; 10
Schroder, Tschopp (bb0100) 2010; 140
Pandey, Rizavi, Zhang (bb0050) 2018; 43
Tonelli, Stiller, Rujescu (bb0040) 2008; 117
Wohleb, Franklin, Iwata (bb0025) 2016; 17
Vanaja, Rathinam, Fitzgerald (bb0205) 2015; 25
McAfoose, Baune (bb0275) 2009; 33
McAfoose, Koerner, Baune (bb0280) 2009; 34
de Rivero Vaccari, Dietrich, Keane (bb0170) 2014; 34
Pan, Chen, Zhang (bb0195) 2014; 41
Zhou, Shi, Wang (bb0150) 2016; 2016
Martinon, Burns, Tschopp (bb0105) 2002; 10
Franchi, Park, Shaw (bb0240) 2008; 10
Ojala, Alafuzoff, Herukka (bb0300) 2009; 30
Bergsbaken, Fink, Cookson (bb0290) 2009; 7
Pandey, Rizavi, Ren (bb0095) 2014; 53
Shi, Wang, Li (bb0200) 2016; 17
Lowry, Rosebrough, Farr (bb0125) 1951; 193
Schiepers, Wichers, Maes (bb0020) 2005; 29
Nakahira, Haspel, Rathinam (bb0260) 2011; 12
Kumar, Kawai, Akira (bb0085) 2011; 30
Hanamsagar, Torres, Kielian (bb0115) 2011; 119
Alcocer-Gomez, de Miguel, Casas-Barquero (bb0180) 2014; 36
Song, Pei, Yao (bb0160) 2017; 11
Suzuki, Franchi, Toma (bb0295) 2007; 3
Iwata, Ota, Duman (bb0270) 2013; 31
Rosenzweig, Planck, Rosenbaum (bb0055) 2011; 11
Swanson, Deng, Ting (bb0145) 2019; 19
Pandey, Dwivedi, SridharaRao (bb0130) 2002; 26
Andreazza, Shao, Wang (bb0265) 2010; 67
Glass, Saijo, Winner (bb0165) 2010; 140
Martinon, Petrilli, Mayor (bb0255) 2006; 440
Pandey, Rizavi, Bhaumik (bb0090) 2019; 75
Anderson, Mueller, Rosengren (bb0140) 2004; 338
First, Spitzer, Gibbon (bb0120) 1997
Gillespie, Horwood (bb0135) 1998; 9
Syed, Beurel, Loewenstein (bb0185) 2018; 99
Meng, Zhang, Fuss (bb0220) 2009; 30
Takeuchi, Akira (bb0075) 2010; 140
Black, Miller (bb0015) 2015; 78
Agostini, Martinon, Burns (bb0110) 2004; 20
Gasse, Riteau, Charron (bb0245) 2009; 179
Pandey, Rizavi, Ren (bb0045) 2012; 46
Dowlati, Herrmann, Swardfager (bb0030) 2010; 67
Zambetti, Laudisi, Licandro (bb0215) 2012; 53
Takeuchi O (b14-46-5-e538/b14-46-5-e538_1) 2010; 140
McAfoose J (b54-46-5-e538/b54-46-5-e538_1) 2009; 33
Song L (b31-46-5-e538/b31-46-5-e538_1) 2017; 11
Alcocer-Gomez E (b37-46-5-e538/b37-46-5-e538_1) 2016; 53
McAfoose J (b55-46-5-e538/b55-46-5-e538_1) 2009; 34
Pandey GN (b25-46-5-e538/b25-46-5-e538_1) 2002; 26
Vanaja SK (b40-46-5-e538/b40-46-5-e538_1) 2015; 25
Xu J (b1-46-5-e538/b1-46-5-e538_1) 2020
Pandey GN (b8-46-5-e538/b8-46-5-e538_1) 2012; 46
Suzuki T (b58-46-5-e538/b58-46-5-e538_1) 2007; 3
Hanamsagar R (b22-46-5-e538/b22-46-5-e538_1) 2011; 119
Andreazza AC (b52-46-5-e538/b52-46-5-e538_1) 2010; 67
Martinon F (b20-46-5-e538/b20-46-5-e538_1) 2002; 10
First MB (b23-46-5-e538/b23-46-5-e538_1) 1997
Heneka MT (b56-46-5-e538/b56-46-5-e538_1) 2013; 493
Griffith JW (b49-46-5-e538/b49-46-5-e538_1) 2009; 183
Zhou K (b29-46-5-e538/b29-46-5-e538_1) 2016; 2016
Kumar H (b16-46-5-e538/b16-46-5-e538_1) 2011; 30
Schroder K (b30-46-5-e538/b30-46-5-e538_1) 2010; 327
Swanson KV (b28-46-5-e538/b28-46-5-e538_1) 2019; 19
Mariathasan S (b44-46-5-e538/b44-46-5-e538_1) 2004; 430
Martinon F (b50-46-5-e538/b50-46-5-e538_1) 2006; 440
Pandey GN (b18-46-5-e538/b18-46-5-e538_1) 2014; 53
Franchi L (b47-46-5-e538/b47-46-5-e538_1) 2008; 10
Syed SA (b36-46-5-e538/b36-46-5-e538_1) 2018; 99
Gasse P (b48-46-5-e538/b48-46-5-e538_1) 2009; 179
Pan Y (b38-46-5-e538/b38-46-5-e538_1) 2014; 41
Gillespie MT (b26-46-5-e538/b26-46-5-e538_1) 1998; 9
de Rivero Vaccari JP (b33-46-5-e538/b33-46-5-e538_1) 2014; 34
Shi H (b39-46-5-e538/b39-46-5-e538_1) 2016; 17
Franchi L (b12-46-5-e538/b12-46-5-e538_1) 2009; 10
Iyer SS (b45-46-5-e538/b45-46-5-e538_1) 2013; 39
White CS (b60-46-5-e538/b60-46-5-e538_1) 2017; 27
Lowry OH (b24-46-5-e538/b24-46-5-e538_1) 1951; 193
Meng G (b43-46-5-e538/b43-46-5-e538_1) 2009; 30
Schiepers OJ (b3-46-5-e538/b3-46-5-e538_1) 2005; 29
Zambetti LP (b42-46-5-e538/b42-46-5-e538_1) 2012; 53
Wohleb ES (b4-46-5-e538/b4-46-5-e538_1) 2016; 17
Lampron A (b11-46-5-e538/b11-46-5-e538_1) 2013; 78
Pandey GN (b17-46-5-e538/b17-46-5-e538_1) 2019; 75
Kim HK (b34-46-5-e538/b34-46-5-e538_1) 2016; 72
Rosenzweig HL (b10-46-5-e538/b10-46-5-e538_1) 2011; 11
Serafini G (b6-46-5-e538/b6-46-5-e538_1) 2013; 23
Ye Z (b13-46-5-e538/b13-46-5-e538_1) 2008; 20
Ojala J (b59-46-5-e538/b59-46-5-e538_1) 2009; 30
Schroder K (b19-46-5-e538/b19-46-5-e538_1) 2010; 140
Bauernfeind FG (b41-46-5-e538/b41-46-5-e538_1) 2009; 183
Rathinam VA (b15-46-5-e538/b15-46-5-e538_1) 2012; 13
Bergsbaken T (b57-46-5-e538/b57-46-5-e538_1) 2009; 7
Zhou R (b46-46-5-e538/b46-46-5-e538_1) 2011; 469
Nakahira K (b51-46-5-e538/b51-46-5-e538_1) 2011; 12
Pandey GN (b9-46-5-e538/b9-46-5-e538_1) 2018; 43
Dowlati Y (b5-46-5-e538/b5-46-5-e538_1) 2010; 67
Agostini L (b21-46-5-e538/b21-46-5-e538_1) 2004; 20
Iwata M (b53-46-5-e538/b53-46-5-e538_1) 2013; 31
Glass CK (b32-46-5-e538/b32-46-5-e538_1) 2010; 140
Black C (b2-46-5-e538/b2-46-5-e538_1) 2015; 78
Anderson JP (b27-46-5-e538/b27-46-5-e538_1) 2004; 338
Tonelli LH (b7-46-5-e538/b7-46-5-e538_1) 2008; 117
Alcocer-Gomez E (b35-46-5-e538/b35-46-5-e538_1) 2014; 36
References_xml – volume: 75
  start-page: 101
  year: 2019
  end-page: 111
  ident: bb0090
  article-title: Innate immunity in the postmortem brain of depressed and suicide subjects: role of toll-like receptors
  publication-title: Brain Behav Immun
– volume: 10
  start-page: 1
  year: 2008
  end-page: 8
  ident: bb0240
  article-title: Intracellular NOD-like receptors in innate immunity, infection and disease
  publication-title: Cell Microbiol
– year: 2020
  ident: bb0010
  article-title: Mortality in the United States, 2018
  publication-title: NCHS Data Brief no. 355
– volume: 67
  start-page: 446
  year: 2010
  end-page: 457
  ident: bb0030
  article-title: A meta-analysis of cytokines in major depression
  publication-title: Biol Psychiatry
– volume: 72
  start-page: 43
  year: 2016
  end-page: 50
  ident: bb0175
  article-title: Nod-like receptor pyrin containing 3 (NLRP3) in the post-mortem frontal cortex from patients with bipolar disorder: a potential mediator between mitochondria and immune-activation
  publication-title: J Psychiatr Res
– volume: 27
  start-page: 223
  year: 2017
  end-page: 234
  ident: bb0305
  article-title: Inflammasomes as therapeutic targets for Alzheimer’s disease
  publication-title: Brain Pathol
– volume: 53
  start-page: 62
  year: 2014
  end-page: 68
  ident: bb0095
  article-title: Toll-like receptors in the depressed and suicide brain
  publication-title: J Psychiatr Res
– volume: 140
  start-page: 821
  year: 2010
  end-page: 832
  ident: bb0100
  article-title: The inflammasomes
  publication-title: Cell
– volume: 11
  start-page: 63
  year: 2017
  ident: bb0160
  article-title: NLRP3 inflammasome in neurological diseases, from functions to therapies
  publication-title: Front Cell Neurosci
– volume: 36
  start-page: 111
  year: 2014
  end-page: 117
  ident: bb0180
  article-title: NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder
  publication-title: Brain Behav Immun
– volume: 31
  start-page: 105
  year: 2013
  end-page: 114
  ident: bb0270
  article-title: The inflammasome: pathways linking psychological stress, depression, and systemic illnesses
  publication-title: Brain Behav Immun
– volume: 338
  start-page: 25
  year: 2004
  end-page: 34
  ident: bb0140
  article-title: Structural, expression, and evolutionary analysis of mouse CIAS1
  publication-title: Gene
– volume: 12
  start-page: 222
  year: 2011
  end-page: 230
  ident: bb0260
  article-title: Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome
  publication-title: Nat Immunol
– volume: 10
  start-page: 241
  year: 2009
  end-page: 247
  ident: bb0065
  article-title: The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis
  publication-title: Nat Immunol
– volume: 440
  start-page: 237
  year: 2006
  end-page: 241
  ident: bb0255
  article-title: Gout-associated uric acid crystals activate the NALP3 inflammasome
  publication-title: Nature
– volume: 183
  start-page: 5208
  year: 2009
  end-page: 5220
  ident: bb0250
  article-title: Pure hemozoin is inflammatory in vivo and activates the NALP3 inflammasome via release of uric acid
  publication-title: J Immunol
– volume: 183
  start-page: 787
  year: 2009
  end-page: 791
  ident: bb0210
  article-title: Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression
  publication-title: J Immunol
– volume: 30
  start-page: 860
  year: 2009
  end-page: 874
  ident: bb0220
  article-title: A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses
  publication-title: Immunity
– volume: 469
  start-page: 221
  year: 2011
  end-page: 225
  ident: bb0235
  article-title: A role for mitochondria in NLRP3 inflammasome activation
  publication-title: Nature
– volume: 20
  start-page: 3
  year: 2008
  end-page: 9
  ident: bb0070
  article-title: NLR, the nucleotide-binding domain leucine-rich repeat containing gene family
  publication-title: Curr Opin Immunol
– volume: 39
  start-page: 311
  year: 2013
  end-page: 323
  ident: bb0230
  article-title: Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation
  publication-title: Immunity
– volume: 140
  start-page: 805
  year: 2010
  end-page: 820
  ident: bb0075
  article-title: Pattern recognition receptors and inflammation
  publication-title: Cell
– volume: 67
  start-page: 360
  year: 2010
  end-page: 368
  ident: bb0265
  article-title: Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder
  publication-title: Arch Gen Psychiatry
– volume: 78
  start-page: 28
  year: 2015
  end-page: 37
  ident: bb0015
  article-title: Meta-analysis of cytokines and chemokines in suicidality: distinguishing suicidal versus nonsuicidal patients
  publication-title: Biol Psychiatry
– year: 1997
  ident: bb0120
  article-title: Structured clinical interview
– volume: 140
  start-page: 918
  year: 2010
  end-page: 934
  ident: bb0165
  article-title: Mechanisms underlying inflammation in neurodegeneration
  publication-title: Cell
– volume: 99
  start-page: e913
  year: 2018
  end-page: e924
  ident: bb0185
  article-title: Defective inflammatory pathways in never-treated depressed patients are associated with poor treatment response
  publication-title: Neuron
– volume: 17
  start-page: 250
  year: 2016
  end-page: 258
  ident: bb0200
  article-title: NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component
  publication-title: Nat Immunol
– volume: 43
  start-page: 376
  year: 2018
  end-page: 385
  ident: bb0050
  article-title: Abnormal protein and mRNA expression of inflammatory cytokines in the prefrontal cortex of depressed individuals who died by suicide
  publication-title: J Psychiatry Neurosci
– volume: 327
  start-page: 296
  year: 2010
  end-page: 300
  ident: bb0155
  article-title: The NLRP3 inflammasome: a sensor for metabolic danger?
  publication-title: Science
– volume: 78
  start-page: 214
  year: 2013
  end-page: 232
  ident: bb0060
  article-title: Innate immunity in the CNS: redefining the relationship between the CNS and its environment
  publication-title: Neuron
– volume: 30
  start-page: 16
  year: 2011
  end-page: 34
  ident: bb0085
  article-title: Pathogen recognition by the innate immune system
  publication-title: Int Rev Immunol
– volume: 493
  start-page: 674
  year: 2013
  end-page: 678
  ident: bb0285
  article-title: NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
  publication-title: Nature
– volume: 11
  start-page: 423
  year: 2011
  end-page: 428
  ident: bb0055
  article-title: NLRs in immune privileged sites
  publication-title: Curr Opin Pharmacol
– volume: 13
  start-page: 333
  year: 2012
  end-page: 342
  ident: bb0080
  article-title: Regulation of inflammasome signaling
  publication-title: Nat Immunol
– volume: 2016
  start-page: 9238290
  year: 2016
  ident: bb0150
  article-title: Recent advances of the NLRP3 inflammasome in central nervous system disorders
  publication-title: J Immunol Res
– volume: 53
  start-page: 4874
  year: 2016
  end-page: 4882
  ident: bb0190
  article-title: Stress-induced depressive behaviors require a functional NLRP3 inflammasome
  publication-title: Mol Neurobiol
– volume: 33
  start-page: 355
  year: 2009
  end-page: 366
  ident: bb0275
  article-title: Evidence for a cytokine model of cognitive function
  publication-title: Neurosci Biobehav Rev
– volume: 30
  start-page: 198
  year: 2009
  end-page: 209
  ident: bb0300
  article-title: Expression of interleukin-18 is increased in the brains of Alzheimer’s disease patients
  publication-title: Neurobiol Aging
– volume: 34
  start-page: 369
  year: 2014
  end-page: 375
  ident: bb0170
  article-title: Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury
  publication-title: J Cereb Blood Flow Metab
– volume: 26
  start-page: 216
  year: 2002
  end-page: 228
  ident: bb0130
  article-title: Protein kinase C and phospholipase C activity and expression of their specific isozymes is decreased and expression of MARCKS is increased in platelets of bipolar but not in unipolar patients
  publication-title: Neuropsychopharmacology
– volume: 119
  start-page: 736
  year: 2011
  end-page: 748
  ident: bb0115
  article-title: Inflammasome activation and IL-1beta/IL-18 processing are influenced by distinct pathways in microglia
  publication-title: J Neurochem
– volume: 41
  start-page: 90
  year: 2014
  end-page: 100
  ident: bb0195
  article-title: Microglial NLRP3 inflammasome activation mediates IL-1beta-related inflammation in prefrontal cortex of depressive rats
  publication-title: Brain Behav Immun
– volume: 29
  start-page: 201
  year: 2005
  end-page: 217
  ident: bb0020
  article-title: Cytokines and major depression
  publication-title: Prog Neuropsychopharmacol Biol Psychiatry
– volume: 23
  start-page: 1672
  year: 2013
  end-page: 1686
  ident: bb0035
  article-title: The role of inflammatory cytokines in suicidal behavior: a systematic review
  publication-title: Eur Neuropsychopharmacol
– volume: 25
  start-page: 308
  year: 2015
  end-page: 315
  ident: bb0205
  article-title: Mechanisms of inflammasome activation: recent advances and novel insights
  publication-title: Trends Cell Biol
– volume: 17
  start-page: 497
  year: 2016
  end-page: 511
  ident: bb0025
  article-title: Integrating neuroimmune systems in the neurobiology of depression
  publication-title: Nat Rev Neurosci
– volume: 19
  start-page: 477
  year: 2019
  end-page: 489
  ident: bb0145
  article-title: The NLRP3 inflammasome: molecular activation and regulation to therapeutics
  publication-title: Nat Rev Immunol
– volume: 7
  start-page: 99
  year: 2009
  end-page: 109
  ident: bb0290
  article-title: Pyroptosis: host cell death and inflammation
  publication-title: Nat Rev Microbiol
– volume: 46
  start-page: 57
  year: 2012
  end-page: 63
  ident: bb0045
  article-title: Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims
  publication-title: J Psychiatr Res
– volume: 117
  start-page: 198
  year: 2008
  end-page: 206
  ident: bb0040
  article-title: Elevated cytokine expression in the orbitofrontal cortex of victims of suicide
  publication-title: Acta Psychiatr Scand
– volume: 20
  start-page: 319
  year: 2004
  end-page: 325
  ident: bb0110
  article-title: NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder
  publication-title: Immunity
– volume: 193
  start-page: 265
  year: 1951
  end-page: 275
  ident: bb0125
  article-title: Protein measurement with the Folin phenol reagent
  publication-title: J Biol Chem
– volume: 34
  start-page: 615
  year: 2009
  end-page: 619
  ident: bb0280
  article-title: The effects of TNF deficiency on age-related cognitive performance
  publication-title: Psychoneuroendocrinology
– volume: 430
  start-page: 213
  year: 2004
  end-page: 218
  ident: bb0225
  article-title: Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
  publication-title: Nature
– volume: 179
  start-page: 903
  year: 2009
  end-page: 913
  ident: bb0245
  article-title: Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis
  publication-title: Am J Respir Crit Care Med
– volume: 10
  start-page: 417
  year: 2002
  end-page: 426
  ident: bb0105
  article-title: The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta
  publication-title: Mol Cell
– volume: 9
  start-page: 109
  year: 1998
  end-page: 116
  ident: bb0135
  article-title: Interleukin-18: perspectives on the newest interleukin
  publication-title: Cytokine Growth Factor Rev
– volume: 53
  start-page: 78
  year: 2012
  end-page: 90
  ident: bb0215
  article-title: The rhapsody of NLRPs: master players of inflammation ... and a lot more
  publication-title: Immunol Res
– volume: 3
  start-page: e111
  year: 2007
  ident: bb0295
  article-title: Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages
  publication-title: PLoS Pathog
– volume: 11
  start-page: 423
  year: 2011
  ident: b10-46-5-e538/b10-46-5-e538_1
  publication-title: Curr Opin Pharmacol
  doi: 10.1016/j.coph.2011.07.002
– volume: 31
  start-page: 105
  year: 2013
  ident: b53-46-5-e538/b53-46-5-e538_1
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2012.12.008
– volume: 140
  start-page: 821
  year: 2010
  ident: b19-46-5-e538/b19-46-5-e538_1
  publication-title: Cell
  doi: 10.1016/j.cell.2010.01.040
– volume: 30
  start-page: 16
  year: 2011
  ident: b16-46-5-e538/b16-46-5-e538_1
  publication-title: Int Rev Immunol
  doi: 10.3109/08830185.2010.529976
– volume: 119
  start-page: 736
  year: 2011
  ident: b22-46-5-e538/b22-46-5-e538_1
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.2011.07481.x
– volume: 67
  start-page: 446
  year: 2010
  ident: b5-46-5-e538/b5-46-5-e538_1
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2009.09.033
– volume: 179
  start-page: 903
  year: 2009
  ident: b48-46-5-e538/b48-46-5-e538_1
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.200808-1274OC
– volume: 43
  start-page: 376
  year: 2018
  ident: b9-46-5-e538/b9-46-5-e538_1
  publication-title: J Psychiatry Neurosci
  doi: 10.1503/jpn.170192
– volume: 34
  start-page: 615
  year: 2009
  ident: b55-46-5-e538/b55-46-5-e538_1
  publication-title: Psychoneuroendocrinology
  doi: 10.1016/j.psyneuen.2008.10.006
– volume: 36
  start-page: 111
  year: 2014
  ident: b35-46-5-e538/b35-46-5-e538_1
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2013.10.017
– volume: 9
  start-page: 109
  year: 1998
  ident: b26-46-5-e538/b26-46-5-e538_1
  publication-title: Cytokine Growth Factor Rev
  doi: 10.1016/S1359-6101(98)00004-5
– volume: 2016
  start-page: 9238290
  year: 2016
  ident: b29-46-5-e538/b29-46-5-e538_1
  publication-title: J Immunol Res
– volume: 12
  start-page: 222
  year: 2011
  ident: b51-46-5-e538/b51-46-5-e538_1
  publication-title: Nat Immunol
  doi: 10.1038/ni.1980
– volume: 78
  start-page: 28
  year: 2015
  ident: b2-46-5-e538/b2-46-5-e538_1
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2014.10.014
– volume: 20
  start-page: 3
  year: 2008
  ident: b13-46-5-e538/b13-46-5-e538_1
  publication-title: Curr Opin Immunol
  doi: 10.1016/j.coi.2008.01.003
– volume: 338
  start-page: 25
  year: 2004
  ident: b27-46-5-e538/b27-46-5-e538_1
  publication-title: Gene
  doi: 10.1016/j.gene.2004.05.002
– volume: 72
  start-page: 43
  year: 2016
  ident: b34-46-5-e538/b34-46-5-e538_1
  publication-title: J Psychiatr Res
  doi: 10.1016/j.jpsychires.2015.10.015
– volume: 10
  start-page: 1
  year: 2008
  ident: b47-46-5-e538/b47-46-5-e538_1
  publication-title: Cell Microbiol
– volume: 183
  start-page: 787
  year: 2009
  ident: b41-46-5-e538/b41-46-5-e538_1
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0901363
– volume: 27
  start-page: 223
  year: 2017
  ident: b60-46-5-e538/b60-46-5-e538_1
  publication-title: Brain Pathol
  doi: 10.1111/bpa.12478
– volume: 327
  start-page: 296
  year: 2010
  ident: b30-46-5-e538/b30-46-5-e538_1
  publication-title: Science
  doi: 10.1126/science.1184003
– volume: 19
  start-page: 477
  year: 2019
  ident: b28-46-5-e538/b28-46-5-e538_1
  publication-title: Nat Rev Immunol
  doi: 10.1038/s41577-019-0165-0
– volume: 430
  start-page: 213
  year: 2004
  ident: b44-46-5-e538/b44-46-5-e538_1
  publication-title: Nature
  doi: 10.1038/nature02664
– volume: 29
  start-page: 201
  year: 2005
  ident: b3-46-5-e538/b3-46-5-e538_1
  publication-title: Prog Neuropsychopharmacol Biol Psychiatry
  doi: 10.1016/j.pnpbp.2004.11.003
– volume: 75
  start-page: 101
  year: 2019
  ident: b17-46-5-e538/b17-46-5-e538_1
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2018.09.024
– volume: 469
  start-page: 221
  year: 2011
  ident: b46-46-5-e538/b46-46-5-e538_1
  publication-title: Nature
  doi: 10.1038/nature09663
– volume: 3
  start-page: e111
  year: 2007
  ident: b58-46-5-e538/b58-46-5-e538_1
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.0030111
– volume: 493
  start-page: 674
  year: 2013
  ident: b56-46-5-e538/b56-46-5-e538_1
  publication-title: Nature
  doi: 10.1038/nature11729
– volume: 30
  start-page: 198
  year: 2009
  ident: b59-46-5-e538/b59-46-5-e538_1
  publication-title: Neurobiol Aging
  doi: 10.1016/j.neurobiolaging.2007.06.006
– volume: 10
  start-page: 241
  year: 2009
  ident: b12-46-5-e538/b12-46-5-e538_1
  publication-title: Nat Immunol
  doi: 10.1038/ni.1703
– volume: 34
  start-page: 369
  year: 2014
  ident: b33-46-5-e538/b33-46-5-e538_1
  publication-title: J Cereb Blood Flow Metab
  doi: 10.1038/jcbfm.2013.227
– volume: 440
  start-page: 237
  year: 2006
  ident: b50-46-5-e538/b50-46-5-e538_1
  publication-title: Nature
  doi: 10.1038/nature04516
– volume: 53
  start-page: 62
  year: 2014
  ident: b18-46-5-e538/b18-46-5-e538_1
  publication-title: J Psychiatr Res
  doi: 10.1016/j.jpsychires.2014.01.021
– volume-title: Mortality in the United States, 2018
  year: 2020
  ident: b1-46-5-e538/b1-46-5-e538_1
– volume: 10
  start-page: 417
  year: 2002
  ident: b20-46-5-e538/b20-46-5-e538_1
  publication-title: Mol Cell
  doi: 10.1016/S1097-2765(02)00599-3
– volume: 193
  start-page: 265
  year: 1951
  ident: b24-46-5-e538/b24-46-5-e538_1
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(19)52451-6
– volume: 53
  start-page: 78
  year: 2012
  ident: b42-46-5-e538/b42-46-5-e538_1
  publication-title: Immunol Res
  doi: 10.1007/s12026-012-8272-z
– volume: 33
  start-page: 355
  year: 2009
  ident: b54-46-5-e538/b54-46-5-e538_1
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2008.10.005
– volume: 140
  start-page: 918
  year: 2010
  ident: b32-46-5-e538/b32-46-5-e538_1
  publication-title: Cell
  doi: 10.1016/j.cell.2010.02.016
– volume: 53
  start-page: 4874
  year: 2016
  ident: b37-46-5-e538/b37-46-5-e538_1
  publication-title: Mol Neurobiol
  doi: 10.1007/s12035-015-9408-7
– volume: 67
  start-page: 360
  year: 2010
  ident: b52-46-5-e538/b52-46-5-e538_1
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2010.22
– volume: 17
  start-page: 250
  year: 2016
  ident: b39-46-5-e538/b39-46-5-e538_1
  publication-title: Nat Immunol
  doi: 10.1038/ni.3333
– volume: 117
  start-page: 198
  year: 2008
  ident: b7-46-5-e538/b7-46-5-e538_1
  publication-title: Acta Psychiatr Scand
  doi: 10.1111/j.1600-0447.2007.01128.x
– volume: 78
  start-page: 214
  year: 2013
  ident: b11-46-5-e538/b11-46-5-e538_1
  publication-title: Neuron
  doi: 10.1016/j.neuron.2013.04.005
– volume-title: Structured clinical interview for DSM-IV axis I disorders (SCID-I)
  year: 1997
  ident: b23-46-5-e538/b23-46-5-e538_1
– volume: 99
  start-page: 914
  year: 2018
  ident: b36-46-5-e538/b36-46-5-e538_1
  publication-title: Neuron
  doi: 10.1016/j.neuron.2018.08.001
– volume: 25
  start-page: 308
  year: 2015
  ident: b40-46-5-e538/b40-46-5-e538_1
  publication-title: Trends Cell Biol
  doi: 10.1016/j.tcb.2014.12.009
– volume: 7
  start-page: 99
  year: 2009
  ident: b57-46-5-e538/b57-46-5-e538_1
  publication-title: Nat Rev Microbiol
  doi: 10.1038/nrmicro2070
– volume: 11
  start-page: 63
  year: 2017
  ident: b31-46-5-e538/b31-46-5-e538_1
  publication-title: Front Cell Neurosci
– volume: 46
  start-page: 57
  year: 2012
  ident: b8-46-5-e538/b8-46-5-e538_1
  publication-title: J Psychiatr Res
  doi: 10.1016/j.jpsychires.2011.08.006
– volume: 30
  start-page: 860
  year: 2009
  ident: b43-46-5-e538/b43-46-5-e538_1
  publication-title: Immunity
  doi: 10.1016/j.immuni.2009.04.012
– volume: 140
  start-page: 805
  year: 2010
  ident: b14-46-5-e538/b14-46-5-e538_1
  publication-title: Cell
  doi: 10.1016/j.cell.2010.01.022
– volume: 39
  start-page: 311
  year: 2013
  ident: b45-46-5-e538/b45-46-5-e538_1
  publication-title: Immunity
  doi: 10.1016/j.immuni.2013.08.001
– volume: 26
  start-page: 216
  year: 2002
  ident: b25-46-5-e538/b25-46-5-e538_1
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(01)00327-X
– volume: 183
  start-page: 5208
  year: 2009
  ident: b49-46-5-e538/b49-46-5-e538_1
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0713552
– volume: 17
  start-page: 497
  year: 2016
  ident: b4-46-5-e538/b4-46-5-e538_1
  publication-title: Nat Rev Neurosci
  doi: 10.1038/nrn.2016.69
– volume: 13
  start-page: 333
  year: 2012
  ident: b15-46-5-e538/b15-46-5-e538_1
  publication-title: Nat Immunol
  doi: 10.1038/ni.2237
– volume: 41
  start-page: 90
  year: 2014
  ident: b38-46-5-e538/b38-46-5-e538_1
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2014.04.007
– volume: 23
  start-page: 1672
  year: 2013
  ident: b6-46-5-e538/b6-46-5-e538_1
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2013.06.002
– volume: 20
  start-page: 319
  year: 2004
  ident: b21-46-5-e538/b21-46-5-e538_1
  publication-title: Immunity
  doi: 10.1016/S1074-7613(04)00046-9
SSID ssj0002015
Score 2.516385
Snippet Abnormalities of inflammation have been implicated in the pathophysiology of depression and suicide, based on observations of increased levels of...
ABSTRACTBackgroundAbnormalities of inflammation have been implicated in the pathophysiology of depression and suicide, based on observations of increased...
Background: Abnormalities of inflammation have been implicated in the pathophysiology of depression and suicide, based on observations of increased levels of...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage E538
SubjectTerms Adult
Autopsy
Brain
Brain - metabolism
Cell receptors
Cellular proteins
Cytokines - metabolism
Depression - immunology
Depression, Mental
Female
Humans
Immunity, Innate
Inflammasomes - metabolism
Male
NLR Proteins - immunology
Physiological aspects
Psychiatric/Mental Health
Pyrin
Research Paper
RNA, Messenger
Suicide
Suicide, Completed
Toll-Like Receptors - metabolism
Title Innate immunity receptors in depression and suicide: upregulated NOD-like receptors containing pyrin (NLRPs) and hyperactive inflammasomes in the postmortem brains of people who were depressed and died by suicide
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1180488223000604
https://www.clinicalkey.es/playcontent/1-s2.0-S1180488223000604
https://www.ncbi.nlm.nih.gov/pubmed/34588173
https://www.proquest.com/docview/2578152990
https://pubmed.ncbi.nlm.nih.gov/PMC8526128
Volume 46
WOSCitedRecordID wos000708626700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: ProQuest Canadian Business & Current Affairs Database (NC LIVE)
  customDbUrl:
  eissn: 1488-2434
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002015
  issn: 1180-4882
  databaseCode: 8FQ
  dateStart: 19990301
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/cbcacomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1488-2434
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002015
  issn: 1180-4882
  databaseCode: BENPR
  dateStart: 19990301
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Proquest Health and Medical Complete
  customDbUrl:
  eissn: 1488-2434
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002015
  issn: 1180-4882
  databaseCode: 7X7
  dateStart: 19990301
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Nursing & Allied Health Database
  customDbUrl:
  eissn: 1488-2434
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002015
  issn: 1180-4882
  databaseCode: 7RV
  dateStart: 19990301
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Publicly Available Content
  customDbUrl:
  eissn: 1488-2434
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002015
  issn: 1180-4882
  databaseCode: PIMPY
  dateStart: 19990301
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Science Database (NC LIVE)
  customDbUrl:
  eissn: 1488-2434
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002015
  issn: 1180-4882
  databaseCode: M2P
  dateStart: 19990301
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Psychology Database
  customDbUrl:
  eissn: 1488-2434
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002015
  issn: 1180-4882
  databaseCode: M2M
  dateStart: 19990301
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/psychology
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Research Library
  customDbUrl:
  eissn: 1488-2434
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002015
  issn: 1180-4882
  databaseCode: M2O
  dateStart: 19990301
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/pqrl
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamDSFeEHfKxmQEAqEqkGtj8wZj0ybRrpSBypOVOgkNrElpml3-I3-Gf8CxnTjJ6BA88GK18Ynj5Hw5PnbO-YzQkzgMXR54gUHBGYUJShga4EZwA1yjwPLj2KQTuWvJO38wIOMxHa6t_axyYU6O_TQlZ2d0_l9VDcdA2SJ19h_UrRuFA_AblA4lqB3Kv1L8QZqC_9hNZOIHuNhg0qK53FOnGfiqYpDzIuFJKNPTC6iQ29KDBzo4fGscJ9-ixrkipF1tJtGdny8SdfoUJrEyy-pEUI_EAK5ZkGczGeOlcrCyfDmT4bzdidiLQsaNqKD17uk0655Gi6jqUyRJY7th6ROXXbvEea6DtCV2G6ycGqhDsTyu8nCmMB5Pz4NZ_d1Jr5PvF4leZJIs3irKs1gE4VSPWCNlm8dw90XWXCexLR0IVoaRjHZ0MGMrvEVYfYuYBliy1rBQrowmzQ_v0sbveoqP5rfBxzMFCcbXefrCFsxWFxi-Fclwj8DFXFesMm3YvkeFIfbHeo0AnHe56YbuUcmoC02_rBu-zIe66FQ0vKp2xG_DhTq6ga6X6sOvFWZvorUovYWu9svojtvoh4IurqCLNfxwkuIauhg0i0t8vMIN4OIKuI0za-BiCVx5cgO4uAVccSEALq6BixVwcRZjBVwMwMUCuFgDV7YpgIsn51XH7qCPe7tHO_tGuduIwXsmWRq2zblFSOAIijsrsLjLqdMLHOq5E-o7cUh45MZB7EBpgxYnLg1MB-Roj8NAGTl30XqapdF9hInJCczjHV-wQbq-TynxetSMoCmXxHTSQc8r_TFeUvGLHWGOmZiSg64Z6JopXXfQYy07VwQ0K6W6FQxYlVINTgADaK6U9ldJR3lpxnJmsdxmJvsgcChgaDuSucntoGcCY0zgHnrMgzKJB-5b8MixGt8dtNmS5PPkO2vUPm3VflEc-6ua2WoJwuDHW9WPKrAzUSUiRtMoK3ImXBGYm4Cz3UH3FPj183NEer7lO_AcWq-FFhCc--2aNJlK7n3iCc5F8uDP3dpE12oTtIXWl4sieoiu8JNlki-24Y0ffdqW770sCZRk7_022nizOxiO4F_f7svyUJZDqBke9IeffwF_ul57
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Innate+immunity+receptors+in+depression+and+suicide%3A+upregulated+NOD-like+receptors+containing+pyrin+and+hyperactive+inflammasomes+in+the+postmortem+brains+of+people+who+were+depressed+and+died+by+suicide&rft.jtitle=Journal+of+psychiatry+%26+neuroscience&rft.au=Pandey%2C+Ghanshyam+N&rft.au=Zhang%2C+Hui&rft.au=Sharma%2C+Anuradha&rft.au=Ren%2C+Xinguo&rft.date=2021-09-01&rft.pub=NRC+Research+Press&rft.issn=1180-4882&rft.volume=46&rft.issue=5&rft.spage=E538&rft_id=info:doi/10.1503%2Fjpn.210016&rft.externalDocID=A681184450
thumbnail_m http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F11804882%2FS1180488221X65006%2Fcov150h.gif